251 related articles for article (PubMed ID: 29267209)
1. Variability of MMP/TIMP and TGF-β1 Receptors throughout the Clinical Progression of Chronic Venous Disease.
Serralheiro P; Novais A; Cairrão E; Maia C; Costa Almeida CM; Verde I
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267209
[TBL] [Abstract][Full Text] [Related]
2. Effect of TGF-beta1 on MMP/TIMP and TGF-beta1 receptors in great saphenous veins and its significance on chronic venous insufficiency.
Serralheiro P; Cairrão E; Maia CJ; João M; Almeida CMC; Verde I
Phlebology; 2017 Jun; 32(5):334-341. PubMed ID: 27329669
[TBL] [Abstract][Full Text] [Related]
3. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
[TBL] [Abstract][Full Text] [Related]
4. Disequilibrium in MMPs and the tissue inhibitor of metalloproteinases in different segments of the varicose great saphenous vein wall.
Hu X; Hu F; Xu Y; Tang J; Chu H; Zhong Y
Int Angiol; 2019 Jun; 38(3):185-193. PubMed ID: 31058480
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease.
Moesgaard SG; Aupperle H; Rajamäki MM; Falk T; Rasmussen CE; Zois NE; Olsen LH
Res Vet Sci; 2014 Dec; 97(3):560-7. PubMed ID: 25458505
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
Pietruszewska W; Bojanowska-Poźniak K; Kobos J
Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
[TBL] [Abstract][Full Text] [Related]
7. Influence of LPS, TNF, TGF-ß1 and IL-4 on the expression of MMPs, TIMPs and selected cytokines in rat synovial membranes incubated in vitro.
Hyc A; Osiecka-Iwan A; Niderla-Bielinska J; Moskalewski S
Int J Mol Med; 2011 Jan; 27(1):127-37. PubMed ID: 21069256
[TBL] [Abstract][Full Text] [Related]
8. Effect of transforming growth factor-beta1 antisense oligonucleotides on matrix metalloproteinases and their inhibitors in keloid fibroblasts.
Bran GM; Goessler UR; Baftiri A; Hormann K; Riedel F; Sadick H
Otolaryngol Head Neck Surg; 2010 Jul; 143(1):66-71. PubMed ID: 20620621
[TBL] [Abstract][Full Text] [Related]
9. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support.
Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ
J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of transforming growth factor-beta signaling pathway in the wall of normal and varicose veins.
Kowalewski R; Malkowski A; Sobolewski K; Gacko M
Pathobiology; 2010; 77(1):1-6. PubMed ID: 20185961
[TBL] [Abstract][Full Text] [Related]
11. Morphologic characteristics of varicose veins: possible role of metalloproteinases.
Woodside KJ; Hu M; Burke A; Murakami M; Pounds LL; Killewich LA; Daller JA; Hunter GC
J Vasc Surg; 2003 Jul; 38(1):162-9. PubMed ID: 12844106
[TBL] [Abstract][Full Text] [Related]
12. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
13. The expression of matrix metalloproteinases and their tissue inhibitors in the vein wall following superficial venous thrombosis.
Yu G; Li K; Xu Y; Chu H; Zhan H; Zhong Y
Phlebology; 2022 Feb; 37(1):63-71. PubMed ID: 34494484
[TBL] [Abstract][Full Text] [Related]
14. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
15. Influence of thrombophlebitis on TGF-β1 and its signaling pathway in the vein wall.
Kowalewski R; Malkowski A; Gacko M; Sobolewski K
Folia Histochem Cytobiol; 2010 Dec; 48(4):542-8. PubMed ID: 21478096
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of collagens, HSP47, TGF-beta1, MMPs and TIMPs in epidermolysis bullosa acquisita.
Razzaque MS; Kumari S; Foster CS; Ahmed AR
Cytokine; 2003 Mar; 21(5):207-13. PubMed ID: 12824005
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1.
Ma C; Tarnuzzer RW; Chegini N
Wound Repair Regen; 1999; 7(6):477-85. PubMed ID: 10633007
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
Gomes LR; Terra LF; Wailemann RA; Labriola L; Sogayar MC
BMC Cancer; 2012 Jan; 12():26. PubMed ID: 22260435
[TBL] [Abstract][Full Text] [Related]
19. Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: does the skin reflect venous matrix changes?
Sansilvestri-Morel P; Fioretti F; Rupin A; Senni K; Fabiani JN; Godeau G; Verbeuren TJ
Clin Sci (Lond); 2007 Feb; 112(4):229-39. PubMed ID: 17020541
[TBL] [Abstract][Full Text] [Related]
20. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
